Previous Article | Next Article ![]()
Journal of Clinical Microbiology, February 2000, p. 530-536, Vol. 38, No. 2
National Institute of Public Health and the
Environment, Bilthoven, The Netherlands1;
Public Health Laboratory Services, Leeds, United
Kingdom2; and Karolinska Institute,
Solna, Sweden3
Received 6 July 1999/Returned for modification 21 September
1999/Accepted 5 November 1999
Sapporo-like viruses (SLVs) are associated with acute
gastroenteritis in humans. Due to a limited supply of available
reagents for diagnosis, little is known about the incidence and
pathogenicity of these viruses. We have developed a first-generation
generic reverse transcriptase (RT) PCR assay based on a single primer pair targeting the RNA polymerase gene. With this assay, 55 (93%) of
the 59 stool specimens collected in a 10-year period of time (1988 to
1998) and containing typical caliciviruses by electron microscopy
tested positive and could be confirmed by Southern hybridization. By
phylogenetic analysis, most SLV strains could be classified into one of
the three recently described genotypes. However, three samples
clustered separately, forming a potential new genotype. We
sequenced the complete capsid gene of one of the strains in this
cluster: Hu/SLV/Stockholm/97/SE. Alignment of the capsid sequences
showed 40 to 74% amino acid identity among strains of the different
clusters. Phylogenetic analysis of the aligned sequences confirmed the
placing of Hu/SLV/Stockholm/97/SE into a new distinct genetic
cluster. This is the first report on the development of a broadly
reactive RT-PCR assay for the detection of SLVs.
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Molecular Detection and Epidemiology of
Sapporo-Like Viruses
*
Corresponding author. Mailing address: Research
Laboratory for Infectious Diseases, Department of Virology, National
Institute of Public Health and the Environment (R.I.V.M.), Antonie van
Leeuwenhoeklaan 9, 3721 MA Bilthoven, The Netherlands. Phone:
(31)-30-2743944. Fax: (31)-30-2744449. E-mail:
Marion.Koopmans{at}rivm.nl.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|